The British Business Bank says it has committed $100 million to SV Health Investors’ new flagship fund, SV8 Biotech Fund LP. This is said to be the Bank’s largest commitment to date. The investment is to support the UK’s Life Sciences Sector Plan.
SV Health Investors is a healthcare fund manager. The SV funds invest across stages, geographic regions, and sectors, with coverage in biotechnology, Healthtech, and more.
In total Bank’s commitments to life sciences is now above half a billion, with £560 million committed across 15 life science funds.
The British Business Bank is the largest investor in UK venture and venture growth capital funds. It has a relationship with SV going back ten years
Leandros Kalisperas, Chief Investment Officer at the British Business Bank, said the investment is good news for UK life sciences.
“The UK’s highest performing companies are in need of greater funding, especially at the growth stage, and we are ramping up our investment activity to meet this demand.”
Nikola Trbovic, Managing Partner, SV Health Investors, said support from the Bank over the last ten years has helped enable them to fund some of the most promising UK Biotech companies.
